ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682827 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682827; 2) Community: the network communities that were significantly associated with the response to NSC 682827; 3) Molecule: the relationships between components within communities and NSC 682827; 4) MDR: the compounds that were significantly associated with the NSC 682827.

NSC Compound Enrichment Correlation
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0462077035966084 0.20767654
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0462077035966084 0.040727419
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0462077035966084 0.19086215
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0462077035966084 0.28752702
NSC 180973 Tamoxifen citrate 0.0462077035966084 0.2781142
NSC 245456 Naphthalene, 2,3-dimethoxy-6-(2-nitroethenyl)- 0.0462077035966084 0.31465809
NSC 256927 CHIP 0.0462077035966084 0.43978875
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0462077035966084 0.38447345
NSC 299934 THAPSIA VILLOSA COMPD 0.0462077035966084 0.13552495
NSC 308847 Amonafide 0.0462077035966084 0.21934093
Total:151  Current:143    [First] [Prev] [Next] [Last]